MTOR and hepatocellular carcinoma: In HCC, Src is expressed in approximately 50% of human tumors derived from either HBV or HCV [31], but few studies have explored Src’s role in other molecular pathways such as mTOR or the utility of specific Src inhibitors to restrict HCC growth.